BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1355821)

  • 1. Cerebrospinal fluid immunocytology in primary central nervous system lymphoma.
    Kranz BR; Thierfelder S; Gerl A; Wilmanns W
    Lancet; 1992 Sep; 340(8821):727. PubMed ID: 1355821
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid interleukin-10 levels in primary central nervous system lymphoma: a possible marker of response to treatment?
    Salmaggi A; Eoli M; Corsini E; Gelati M; Frigerio S; Silvani A; Boiardi A
    Ann Neurol; 2000 Jan; 47(1):137-8. PubMed ID: 10632117
    [No Abstract]   [Full Text] [Related]  

  • 3. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.
    Mahmoud HH; Rivera GK; Hancock ML; Krance RA; Kun LE; Behm FG; Ribeiro RC; Sandlund JT; Crist WM; Pui CH
    N Engl J Med; 1993 Jul; 329(5):314-9. PubMed ID: 8321259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for routine cerebrospinal fluid cytology in detecting asymptomatic central nervous system relapse in children with acute lymphoblastic leukaemia: 20 years' experience of a UK primary treatment centre.
    Manley S; Keenan R; Campbell H; Caswell M; Pizer B
    Br J Haematol; 2014 Feb; 164(3):462-4. PubMed ID: 24422728
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of rare malignant cells and their apoptotic fragments in cerebrospinal fluid.
    Kranz BR
    Lancet; 2000 Oct; 356(9237):1242-4. PubMed ID: 11072949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS-related lymphomas with neurologic manifestations.
    Sweeney CJ; Agger WA
    West J Med; 1997 Jul; 167(1):40-4. PubMed ID: 9265866
    [No Abstract]   [Full Text] [Related]  

  • 7. The diagnostic value of cerebrospinal fluid pleocytosis and protein in the detection of lymphomatous meningitis in primary central nervous system lymphomas.
    Fischer L; Jahnke K; Martus P; Weller M; Thiel E; Korfel A
    Haematologica; 2006 Mar; 91(3):429-30. PubMed ID: 16531273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective cerebrospinal fluid response to intraventricular rituximab in indolent CNS lymphoma.
    Strowd RE; Abuali IA; Grossman SA
    CNS Oncol; 2015; 4(3):131-5. PubMed ID: 25905905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid approach on neuro-oncology.
    Gomes HR
    Arq Neuropsiquiatr; 2013 Sep; 71(9B):677-80. PubMed ID: 24141503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flower-like/clover leaf lymphocytes appear in various diseases: cerebrospinal fluid cytology case with review of the literature.
    Kobayashi M; Horikawa M; Uehara T; Honda T; Kobayashi T; Sakai H
    Diagn Cytopathol; 2015 Jan; 43(1):88-90. PubMed ID: 24610816
    [No Abstract]   [Full Text] [Related]  

  • 11. Utility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphoma.
    Pittman M; Treese S; Chen L; Frater JL; Nguyen TT; Hassan A; Kreisel F
    Arch Pathol Lab Med; 2013 Nov; 137(11):1610-8. PubMed ID: 24168498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward optimal central nervous system-directed treatment in childhood acute lymphoblastic leukemia.
    Pui CH
    J Clin Oncol; 2003 Jan; 21(2):179-81. PubMed ID: 12525506
    [No Abstract]   [Full Text] [Related]  

  • 13. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
    Bossolasco S; Falk KI; Ponzoni M; Ceserani N; Crippa F; Lazzarin A; Linde A; Cinque P
    Clin Infect Dis; 2006 Feb; 42(4):e21-5. PubMed ID: 16421782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma.
    Kuusisto ME; Haapasaari KM; Remes AM; Bloigu R; Karihtala P; Turpeenniemi-Hujanen T; Kuittinen O
    Ann Hematol; 2015 Jul; 94(7):1167-74. PubMed ID: 25697593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis.
    Kimura A; Takemura M; Serrero G; Yoshikura N; Hayashi Y; Saito K; Inuzuka T
    J Neurooncol; 2018 May; 137(3):455-462. PubMed ID: 29340960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma.
    Song Y; Zhang W; Zhang L; Wu W; Zhang Y; Han X; Yang C; Zhang L; Zhou D
    Sci Rep; 2016 Dec; 6():38671. PubMed ID: 27924864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic and prognostic value of interleukin-10 in cerebrospinal fluid for central nervous system lymphoma: a meta-analysis.
    Wang L; Luo L; Gao Z; Liu SF; Liu CJ; Ma DX; Chen JG; Cao WR; Yin AM; Xu JW; Wang SL; Zhuo DJ; Geng B; Zhao SS; Wang FY; Yang N; Guan LX; Gu ZY; Gao CJ
    Leuk Lymphoma; 2017 Oct; 58(10):2452-2459. PubMed ID: 28278715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurement of soluble CD44 in the cerebrospinal fluid of leukemia patients and its significance in the diagnosis of central nervous system leukemia].
    Sun YH; Chen ZX; Jiang M
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):57-8. PubMed ID: 21429404
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue polypeptide-specific antigen (TPS) concentrations in cerebrospinal fluid in patients with breast cancer metastases in the central nervous system.
    Sölétormos G; Bach F
    Clin Chem Lab Med; 2001 Feb; 39(2):170-2. PubMed ID: 11341753
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
    Strehlow F; Bauer S; Martus P; Weller M; Roth P; Schlegel U; Seidel S; Scheibenbogen C; Korfel A; Kreher S
    J Neurooncol; 2016 Aug; 129(1):165-71. PubMed ID: 27294357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.